157 related articles for article (PubMed ID: 9513901)
1. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
Ziswiler R; Steinmann-Niggli K; Kappeler A; Daniel C; Marti HP
J Am Soc Nephrol; 1998 Nov; 9(11):2055-66. PubMed ID: 9808091
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells.
Daniel C; Duffield J; Brunner T; Steinmann-Niggli K; Lods N; Marti HP
J Pharmacol Exp Ther; 2001 Apr; 297(1):57-68. PubMed ID: 11259528
[TBL] [Abstract][Full Text] [Related]
7. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Mitani O; Katoh M; Shigematsu H
Pathol Int; 2004 Apr; 54(4):241-50. PubMed ID: 15028025
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
10. New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Marti HP
Schweiz Med Wochenschr; 2000 May; 130(21):784-8. PubMed ID: 10904987
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid reduces glomerular injury in a rat model of glomerular damage.
Wagner J; Dechow C; Morath C; Lehrke I; Amann K; Waldherr R; Floege J; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1479-1487. PubMed ID: 10906161
[TBL] [Abstract][Full Text] [Related]
12. Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis.
Saglam F; Celik A; Tayfur D; Cavdar Z; Yilmaz O; Sarioglu S; Kolatan E; Oktay G; Camsari T
Nephrology (Carlton); 2010 Aug; 15(5):560-7. PubMed ID: 20649877
[TBL] [Abstract][Full Text] [Related]
13. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
[TBL] [Abstract][Full Text] [Related]
14. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Kase Y; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(10):1710-5. PubMed ID: 20930380
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Clements JM; Cossins JA; Wells GM; Corkill DJ; Helfrich K; Wood LM; Pigott R; Stabler G; Ward GA; Gearing AJ; Miller KM
J Neuroimmunol; 1997 Apr; 74(1-2):85-94. PubMed ID: 9119983
[TBL] [Abstract][Full Text] [Related]
16. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
Chen YM; Chiang WC; Yang Y; Lai CF; Wu KD; Lin SL
Mol Med; 2015 Apr; 21(1):276-84. PubMed ID: 25879629
[TBL] [Abstract][Full Text] [Related]
18. HUANGKUISIWUFANG inhibits pyruvate dehydrogenase to improve glomerular injury in anti-Thy1 nephritis model.
Lu T; Bian Y; Zhu Y; Guo M; Yang Y; Guo J; Gu C; Duan JA
J Ethnopharmacol; 2020 May; 253():112682. PubMed ID: 32087318
[TBL] [Abstract][Full Text] [Related]
19. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis.
Cantaluppi V; Medica D; Mannari C; Stiaccini G; Figliolini F; Dellepiane S; Quercia AD; Migliori M; Panichi V; Giovannini L; Bruno S; Tetta C; Biancone L; Camussi G
Nephrol Dial Transplant; 2015 Mar; 30(3):410-22. PubMed ID: 25488895
[TBL] [Abstract][Full Text] [Related]
20. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
Redford EJ; Smith KJ; Gregson NA; Davies M; Hughes P; Gearing AJ; Miller K; Hughes RA
Brain; 1997 Oct; 120 ( Pt 10)():1895-905. PubMed ID: 9365379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]